Study Design. ADAMTS5-deficient and wild type (WT) mice were chronically exposed to tobacco smoke to investigate effects on intervertebral disc degeneration (IDD).
TOBACCO SMOKING AND INTERVERTEBRAL DISC DEGENERATION
I ntervertebral disc degeneration (IDD) is responsible for many spine-related disorders, including disabling back pain that causes both temporary and permanent disability, resulting in tremendous personal and societal health and economic burden. [1] [2] [3] [4] A growing number of studies, both epidemiological and basic research, demonstrate tobacco smoking as a major risk factor of IDD and back pain. 5, 6 Tobacco smoking has been reported to exacerbate preexisting IDD and increase the frequency of IDD and back pain incidence. 7, 8 Studies using animal models also demonstrate inflammatory and degenerative changes in the intervertebral discs of tobacco smoke-exposed animals. 6, 9 Hence, tobacco smoking greatly affects personal health through initiating and/or exacerbating degenerative disc disorders and back pain. 5 
Smoking-induced Disc Aggrecan Catabolism
A hallmark of IDD is loss of proteoglycan (PG), a major structural matrix constituent vital for maintaining disc turgidity to counteract compressive force. Aggrecan is the major disc PG and endows the tissue with its unique capacity to bear load and resist compression. 10 PG loss is generally attributed to aggrecan catabolism via proteolysis, termed aggrecanolysis, especially under the conditions of genotoxic, oxidative, and inflammatory stress. [10] [11] [12] Tobacco smoke, containing numerous genotoxic and oxidative agents, produces DNA mutations and damage in a variety of tissues. 13 Tobacco smoking also promotes systemic inflammation in many tissues, including the intervertebral discs in which increased interleukin-1b level has been found in smokeexposed rats. 9 Using a mouse model of chronic human smoking, 6 we previously demonstrated disc aggrecanolysis mediated by the action of members of the matrix metalloproteinase (MMP) 14 and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) 15 families. Specifically, we showed that chronic exposure of mice to tobacco smoke induces ADAMTS-mediated cleavage within the interglobular domain (IGD) of disc aggrecan. 6 The IGD consists of $150 amino acids residing between the two globular domains G1 and G2 at the N terminus of aggrecan. IGD cleavage is considered pathological as it releases the majority of the aggrecan, including the entire glycosaminoglycan-attachment region essential for counteracting compressive forces, from the cartilage matrix. 10 
ADAMTS in Smoking-induced Disc Aggrecanolysis
In vivo, the majority of the proteolytic aggrecan IGD cleavage is mediated by the enzymatic activities of MMPs and ADAMTSs. 10 ADAMTS proteins belong to a family of zinc-dependent enzymes within the metzincin family of metalloproteinases. 16 ADAMTS proteins comprise an Nterminal prodomain, a catalytic domain, a disintegrin domain, one or more thrombospondin motifs, a cysteinerich domain, and a spacer domain of variable length.
17
ADAMTS4 and ADAMTS5 are generally considered as the major aggrecanases involved in cartilage erosion. 16 Moreover, transcription of both ADAMTS4 and ADAMTS5 is dependent on activation of NF-kB, a family of transcription factors that play a central role in cellular stress response. [18] [19] [20] Despite a large body of research demonstrating expression of ADAMTS4 and ADAMTS5 proteins and the presence of aggrecan fragments derived by aggrecanase action in degenerative cartilage and disc tissue, it is still unclear whether ADAMTS4 or ADAMTS5 is the primary aggrecanase that drives degeneration in human cartilage and intervertebral disc. 16, 21, 22 Hence, the goal of this study is to determine whether ADAMTS5 is the primary mediator of smoking-induced disc aggrecanolysis. We focused on ADAMTS5 because recombinant human ADAMTS5 exhibits the highest aggrecanase activity among the different metalloproteinases 23 and because mice deficient in ADAMTS5 are protected from cartilage destruction in arthritis models. 24 
MATERIALS AND METHODS

Exposure to Tobacco Smoke
In Vivo Model Three-month-old C57BL/6 mice and ADAMTS5 À/À mice derived from a pure C57BL6 background (Adamts5tm1Dgen/J, Jackson laboratories, ME) were chronically exposed to tobacco smoke (four cigarettes/ day, 5 day/week for 6 months) and intervertebral disc tissue were isolated as previously described. 25 Unexposed age-and sex-matched littermates kept in the same facility environment were used as controls. Nine mice, four females and five males, were used in each treatment condition.
In Vitro Cell Culture Model
Human nucleus pulposus (hNP) cells were isolated from disc surgical specimen harvested from nonsmoking patients as approved by the human subjects Institutional Review Board (n ¼ 8; male:female ¼ 4:4; mean age 48 AE 5 years; mean Pfirrmann grade of 2.5 AE 0.2). First passage cultures of hNP cells grown in monolayer (F-12/D-MEM containing 10% FCS, 1% PS, and 25 mg/ml L-ascorbic acid under 5% O 2 ) were treated with tobacco smoke extract (TSE) at 0.1 mg/mL concentrations for 3 days before being analyzed for various outcome measures described below. This treatment perturbed matrix homeostasis with minimal cell death. 26 
Assessment of Disc Total PGs
Mouse disc PG content was assessed histologically by safranin O/fast green staining and quantitatively by 1,9-dimethylmethylene blue (DMMB) colorimetric assay as described. 6 
Immunohistochemistry
Paraffin-embedded sections were used to probe for ADAMTS-generated neoeptitope NVTEGE as previously described. 6 Immunofluorescence to Measure Smoking-induced Nuclear Factor-kB Activation Mouse Disc Tissue Three-month-old nuclear factor (NF)-kB-transgene expression enhanced green fluorescent protein (eGFP) reporter mice derived from C57BL6 genetic background were treated with and without tobacco smoke for 1 week (early NF-kB activation assessment) and 6 months (chronic NF-kB activation). The NF-kB-eGFP reporter mice contain a knock-in transgene expressing eGFP under the control of an NF-kB regulatory element. 27 In these mice, green fluorescence from eGFP expression indicates activation of the NF-kB signaling pathway. Lumbar discs were harvested, sectioned, and analyzed for cells expressing eGFP by fluorescence microscopy as previously described. 29 hNP Cell Cultures hNP cells grown in monolayer on chamber slides were treated with and without 0.1 mg/mL concentrations of TSE for 3 days. NF-kB activation was assessed in these cells by nuclear translocation of NF-kB, which was visualized by immunofluorescent labeling using an anti-p65 antibody (SC372, Santa Cruz Biotechnology, CA). Nuclear translocation of p65, a subunit of NF-kB, was quantified by calculating the percentage of cells immunopositive for nuclear p65 staining. hNP cell cultures treated with 1 ng/mL of interleukin (IL)-1b were used as a positive control for NF-kB activation.
Western Analysis
Detecting Aggrecan Fragments in Mouse Disc Tissue Entire lumbar discs removed en bloc were analyzed by immunoblot as previously described. 6 Antibodies (1:1000 dilution 1 o Ab, 1:5000 dilution 2 o Ab) were raised against aggrecan G1 (Ab2194) or ADAMTS-generated neoepitope NITEGE (Ab1320). The anti-NITEGE neoepitope antibody cross-reacts with the mouse aggrecan NVTEGE neoepitope.
Detecting Aggrecan Fragments and ADAMTS5 in Conditioned Media of hNP Cell Cultures
Conditioned media from TSE-treated and untreated hNP cell cultures were concentrated three to five times by centrifugal filtering (EMD Millipore UFC900308). Western blotting was performed using Tris-HEPES 4% to 20% gradient gels (Thermo Scientific 25204) with 1:1000 dilution of the 1 o Ab and 1:10000 anti-rabbit goat 2 o Ab conjugated with HRP (Thermo Scientific PI-31460). Rabbit polyclonal antiaggrecan G1 primary antibody (Abcam ab36861) and anti-ADAMTS5 (Abcam ab41037) were used to detect aggrecan fragments and ADAMTS5 protein, respectively. Quantification was performed with densitometry analysis and local background subtraction using the ChemiDoc MP system and associated Image Lab 5.2.1 Software (BioRad, USA).
Statistical Analysis
Values represent the averages from different experimental samples with 95% confidence intervals calculated to determine statistical significance at P 0.05. The confidence intervals were calculated based on the t distribution.
RESULTS Tobacco Smoking-induced Disc ADAMTS5 Protein Expression
Smoking-induced disc aggrecanolysis can be catalyzed by several different aggrecanases, including ADAMTS1, ADAMTS4, and ADAMTS5. Given the demonstrated function of ADAMTS5 as a key aggrecanase in cartilage degradation, we measure ADAMTS5 protein expression by disc cells following exposure to TSE. Immunodetection was performed using an antibody that detects the 73-kDa mature form of secreted ADAMTS5 post-furin cleavage. Western analysis revealed the level of ADAMTS5 protein in the conditioned media of hNP cell cultures treated with TSE to be about twice the level of ADAMTS5 in untreated control ( Figure 1A ). In addition, immunohistochemistry analysis showed a substantial increase in ADAMTS5 ( Figure 1B ) protein levels in NP tissue sections of smokeexposed mice compared to unexposed controls. These results demonstrated that chronic exposure to tobacco smoking upregulates disc ADAMTS5 expression.
Tobacco Smoking Activates Disc NF-kB Signaling
Induction of ADAMTS5 expression has been shown to be dependent on activation of NF-kB, a central signaling pathway cells utilize to respond to stress. There was an increase in the level of nuclear NF-kB following treatment with TSE, consistent with an increase in NF-kB transcriptional activity (Figure 2A ). To determine whether the same phenomenon occurs in vivo, we used knock-in mice expressing eGFP under the control of an NF-kB regulatory element (NFkB-eGFP). In these mice, eGFP expression indicates activation of the NF-kB pathway. Using fluorescent microscopy, an increase in eGFP immunofluorescence was detected in the NP of mice after 6 months of smoke exposure compared to unexposed control ( Figure 2B ), indicating increased NF-kB transcriptional activity in disc tissues of mice exposed to tobacco smoke.
Genetic Deletion of ADAMTS5 Abolished ADAMTSmediated Cleavage Within the Interglobular Domain of Aggrecan in Discs of a Mouse Model of Chronic Human Smoking
Tobacco smoke exposure induced ADAMTS-mediated cleavage of aggrecan IGD in both hNP cell culture model ( Figure 3A ) and the intervertebral discs of the wild type (WT) mice ( Figure 3B, lane 2 vs. lane 3) . The increase in ADAMTS5 expression (Figure 1 ) suggests a correlative, but not a causative relationship to the increase of these proteolytic cleaved aggrecan fragments. To further demonstrate that ADAMTS5 is the major aggrecanase mediating this cleavage, ADAMTS5
À/À mice were used. Western blot was performed using anti-G1 ( Figure 3B, lanes 6-7) and anti-NVTEGE ( Figure 3B, lanes 1-5) antibodies that recognize the neoepitope in aggrecan IGD fragment generated by the ADAMTS. Depletion of ADAMTS5 completely abolished ADAMTS-mediated cleavage of disc aggrecan IGD in mice. For example, the ADAMTS-generated aggrecan G1 fragments terminating in NVTEGE were detected in the discs of smoke-exposed WT mice ( Figure 3B, lane 3) , but not in smoke-exposed ADAMTS5 À/À mice ( Figure 3B , lane 5) or in unexposed control WT mice. These results were further confirmed by immunohistochemistry, wherein aggrecan fragments containing the NVTEGE neoepitope were detected in high level in the discs of smoke-exposed WT mice, but at a reduced level in ADAMTS5 À/À mice ( Figure 3C ).
Genetic Deletion of ADAMTS5 Blunted Disc PG Loss in a Mouse Model of Chronic Human Smoking
WT mice chronically exposed to tobacco smoke for 6 months showed about a 40% loss of NP PG matrix content by the quantitative DMMB assay measuring sulfated GAG compared to unexposed WT control ( Figure 4B ). In contrast, ADAMTS5
À/À mice exposed to smoke for the same period of time demonstrated loss of only 20% NP GAG content compared to unexposed WT control ( Figure 4B ). These results were consistent with safranin O staining of sulfated PGs, which revealed a noticeable reduction of PGs in the discs of WT mice exposed to tobacco smoke and a smaller reduction in discs of ADAMTS5 À/À mice when compared to disc safranin O staining intensity from nonsmoke-exposed WT controls ( Figure 4A ). These findings suggest that smoking-induced loss of disc PG content is mediated considerably by ADAMTS5.
DISCUSSION
Here we focused our efforts in determining whether ADAMTS5 is the major aggrecanase responsible for mediating smoking-induced disc aggrecanolysis. Using both animal and disc cell culture model systems, we Figure 2 . Tobacco smoke activated disc NF-kB signaling. (A) Immunofluorescence revealed increased NFkB activity, as indicated by an increase in the level of nuclear p65, a subunit of NF-kB, in human nucleus pulposus cell cultures following a 15-minute treatment with TSE or IL-1b (positive control) compared to untreated control. Absence (red arrows) and presence (yellow arrows) of nuclear p65. (B) Increased NF-kB activation in disc tissue of mice exposed to tobacco smoke for six months. Top, a schematic representation showing the knock-in reporter mice expressing eGFP under the control of an NF-kB regulatory element (NF-kB eGFP). eGFP expression indicates NF-kB activation. Disc tissue sections from unexposed (nonsmokers) or smoke-exposed (smokers) NF-kB eGFP reporter mice were imaged using fluorescent microscopy to detect eGFP expression (green). Nuclei were counter-stained with Hoechst (blue). Representative images of the nucleus pulposus region are shown. IL indicates interleukin; NF-kB, nuclear factor-kB; TSE, tobacco smoke extract.
demonstrated that exposure to tobacco smoke elevated protein expression of ADAMTS5 and proteolytic cleavage within the disc aggrecan IGD. Importantly, we showed that mice genetically deficient in ADAMTS5 were largely protected from disc aggrecanolysis and loss of PG content following chronic exposure to tobacco smoke for a period of 6 months. Chronic smoke exposure also did not negatively affect vertebral osteoporosity in ADAMTS5 À/À mice, in contrast to that of WT mice (unpublished data). Further studies are required to understand biologically how deficiency in ADAMTS5, a cartilaginous aggrecanase, protects smoking-induced vertebral bone loss. Nonetheless, our data suggest that ADAMTS5 is the prominent aggrecanase that mediates smoking-induced disc aggrecanolysis, and that the absence of ADAMTS5 reduces degeneration of the intervertebral discs and vertebral bone in the mouse model of chronic human tobacco smokers.
Smoking-induced Disc PG Loss
It is important to note that ADAMTS5-deficient mice were not completely protected from smoking-induced disc matrix PG loss. This is because of several possible reasons. Tobacco smoking causes disc PG loss by perturbing disc matrix homeostasis not only by enhancing matrix catabolism but also by suppressing matrix anabolism. 6 New PG synthesis, a marker of matrix anabolism that is measured by the incorporation of 35 S-sulfate, has previously been documented to be 
)]). (B) Immunoblot analysis of G1
fragments bearing the ADAMTS-generated NVTEGE neoepitope was performed using the anti-G1 and anti-NITEGE antibodies. The anti-NITEGE neoepitope antibody cross-reacts with the NVTEGE neoepitope generated from mouse aggrecan. To control for loading, proteins extracted from 1 mg of disc tissue wet weight from unexposed (N) and 6-month smoke-exposed (S)WT and ADAMTS5-deficient (A5 À/À ) mice were loaded per well. (C) Immunohistochemical detection of aggrecan fragments using antibodies raised against the NITEGE neoepitope. Arrow indicates nucleus pulposus sites of detection of positive signal (brown). The bars represent 100 mm. M indicates protein size markers; N, nonsmokers; S, smokers; TSE, tobacco smoke extract; U, untreated; WT, wild type.
suppressed in discs of smoke-exposed WT mice. 6 In the present study, we showed that new PG synthesis in discs of ADAMTS5 À/À mice was also suppressed to a similar extent seen in smoke-exposed WT mice, as expected (data not shown). Moreover, tobacco smoking induces not just ADAMTS but also MMP-generated aggrecan fragments from proteolytic cleavage within the disc aggrecan IGD. ADAMTS5 deficiency abrogates only ADAMTS-mediated, but not MMP-mediated aggrecanolysis in the discs of our mouse smokers. Tobacco smoke increases expression of several MMPs, including MMP1, MMP3, and MMP12 in disc cells. 26 Compared with other MMP members, MMP12 is by far the most efficient at cleaving within the aggrecan IGD. 23 Moreover, MMP12 is recently reported as an indicator of IDD that is coexpressed with fibrotic markers. 29 Tobacco smoking also strongly induces expression of MMP-12, macrophage elastase, in activated macrophages in lung tissues of smokers. 25, 30 However, MMP12 À/À mice did not have a significant reduction in MMP-mediated aggrecan cleavage in our mouse model of tobacco smoking (unpublished data). Thus, further investigation is needed to identify the major MMP(s) responsible for mediating smokinginduced aggrecanolysis in disc tissue. Together, our findings suggest that ADAMTS-5 depletion protects smoke-exposed mice from only the ADAMTS-mediated but not MMPmediated destruction of disc aggrecan; ADAMTS-5 depletion also does not protect smoke-exposed mice from loss of disc PG anabolism.
Mechanism of Smoking-induced Disc ADAMTS5 Expression
The presence of ADAMTS5 has been documented in human intervertebral disc at early and advanced stages of disc degeneration. 31, 32 Disc ADAMTS5 is also found in various disc cell culture and animal models, especially under degenerative and inflammatory conditions. 20, [33] [34] [35] Upregulation of ADAMTS5 mRNA and protein expression is shown to be dependent on NF-kB signaling in disc cells in the presence of the proinflammatory cytokine IL-1b or tumor necrosis factor-a. 20, 34 NF-kB is a central cell-signaling component in mediating cellular response to damage, stress, and inflammation. 36 It is well known that tobacco smoke contains potent proinflammatory agents that cause damage and inflammation in many different body tissues in smokers. 9, 13, 37 In this study, we demonstrated elevated inflammation in disc tissue, as evidenced in enhanced activation of NF-kB signaling, in mice is chronically exposed to direct inhalation of tobacco smoke ( Figure 2B ). This finding is consistent with the reported increase in disc IL-1b in a rat model of passive smokers. 9 Moreover, TSE treatment of our disc cell cultures also elicited strong inflammatory response, evidenced by the pronounced NF-kB activation (Figure 2A ) and COX-2/PGE2 expression. 26 In both disc cell culture and mouse models of tobacco smokers, disc NF-kB activation coincides with ADAMTS5 expression. Taken together, these observations suggest that tobacco smoking induces inflammation in disc tissue leading to NF-kB-dependent expression of ADAMTS5.
Disc Cellular Senescence as a Possible Source of ADAMTS5 Production in Smokers
Cellular senescence, defined by growth arrest, is formed as a result of accumulation of unrepaired DNA damage. 38 Tobacco smoking promotes disc cellular senescence, 6 likely because of the action of the many mutagenic compounds in tobacco smoke. Stress-induced senescent cells are also inflammatory in nature through the activation of NF-kB, as they overproduce and secrete many proinflammatory cytokines and matrix metalloproteinases, termed senescence-associated secretory phenotype. 38, 39 Increased ADAMTS5 expression was positively correlated to the level of P16
INK4A , a marker of cellular senescence, in human degenerative discs. 22 We also found that senescent human disc cell cultures produced increased levels of ADAMTS5 and aggrecan fragments (unpublished data). Thus, senescent disc cells established from smoke exposure could be the cell source that produces ADAMTS5 in the discs of smokers.
In summary, we demonstrated that disc ADAMTS5 protein expression and aggrecanolysis were upregulated by tobacco smoke in both animal and cell culture models. We also demonstrated that mice genetically deficient in ADAMTS5 are protected from ADAMTS-mediated cleavage within the disc aggrecan IGD following chronic exposure to tobacco smoke for 6 months. Furthermore, genetic depletion of ADAMTS5 greatly reduces smokinginduced loss of disc PG and vertebral bone. Taken together, these findings demonstrate that ADAMTS5 is the primary aggrecanase mediating smoking-induced disc aggrecanolysis and IDD and thus represents a potential therapeutic target for mitigating IDD severity in smokers when smoking cessation fails. For example, ADAMTS5 silencing by interference RNA has been reported to reduce injury-induced IDD in rabbits. 40 Because ADAMTS5 expression is NF-kBdependent, NF-kB signaling also offers an alternative therapeutic target to treat IDD. Indeed, NF-kB inhibition mitigates disc degenerative changes in cell culture and animal models. 28, 36, 41 Other targets exist that can be further elucidated using the mouse models of chronic tobacco smoking to probe the mechanisms of IDD.
Key Points
Tobacco smoke contains numerous chemical agents, which cause cellar stress leading to disc PG matrix catabolism. Chronic exposure to tobacco smoke induces NFkB-dependent expression of ADAMTS5 that mediates disc aggrecanolysis.
ADAMTS5 is the primary aggrecanase responsible for smoking-induced disc aggrecanolysis and IDD. ADAMTS5 represents a target for the development of therapeutic inhibitors aimed at delaying the onset or ameliorating the severity of IDD in chronic smokers who fail to quit. Mouse models of chronic human tobacco smokers are useful for investigating the mechanisms of stress-activated aggrecanolysis and IDD.
